Novel Epitranscriptomic Modalities News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Novel Epitranscriptomic Modalities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Novel Epitranscriptomic Modalities Today - Breaking & Trending Today

STORM Therapeutics' First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference

Published: December 8, 2023

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule therapies targeting...

Source: prnewswire.com

Related Topics:

United StatesSan DiegoUnited KingdomJerry McmahonKonstantinos TzelepisCambridge Stem Cell InstitutePrincipal Investigator At University Of CambridgeUniversity Of CambridgeTherapeutics LtdUtokyo Innovation Platform Co LtdIp GroupSeroba Life SciencesTaiho VenturesCambridge Innovation CapitalFast Track InitiativeTherapy ResistanceNovel EpitranscriptomicChief Executive OfficerPrincipal InvestigatorTalk TitleOvercoming Therapy ResistanceNovel Epitranscriptomic ModalitiesStem Cell InstitutePfizer VenturesCambridge Innovation Capitali Limited